More News
16 March 2025
iOncologi, Inc. Acquires TargImmune Therapeutics to Expand and Strengthen Immunotherapy Pipeline Against Solid Tumors3 March 2025
AbbVie and Gubra Announce License Agreement to Develop an Amylin Analog for the Treatment of Obesity28 February 2025
Magnet Biomedicine Enters into a Collaboration and License Agreement with Lilly to Discover and Develop Novel Molecular Glue Medicines26 February 2025
BridGene Biosciences Announces Strategic Collaboration with Takeda to Discover Small Molecule Drugs for Immunology and Neurology Targets22 February 2025
bluebird bio Announces Definitive Agreement to be Acquired by Carlyle and SK Capital12 February 2025
Alloy Therapeutics Establishes Multi-Year Collaboration with Pfizer to Develop New Antibody Discovery Platform10 February 2025
Arrowhead Pharmaceuticals Announces Closing of Global License and Collaboration Agreement with Sarepta Therapeutics10 February 2025
AdvanCell Enters Into Strategic Collaboration with Lilly to Advance Novel Targeted Alpha Therapies for the Treatment of Cancer10 February 2025
OliX and Lilly Enter Global Licensing Agreement for MASH and Other Cardiometabolic Indications7 February 2025
Notice Concerning the Transfer of Mitsubishi Tanabe Pharma Corporation and its Subsidiaries23 January 2025
Strategic Collaboration with Novo Nordisk to Develop Oral Therapies for Sickle Cell Disease and Other Chronic Diseases23 January 2025
AbbVie and Neomorph Announce Collaboration to Develop Molecular Glue Degraders for Oncology and Immunology13 January 2025
Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.13 January 2025
GSK Enters Agreement to Acquire IDRx, Inc.8 January 2025
Variant Bio Announces Multi-Year Research Partnership with Novo Nordisk to Discover Novel Targets for Metabolic Disease3 January 2025
Combination of Poolbeg and HOOKIPA Pharma Inc.2 January 2025
Atavistik Bio Announces Research Collaboration with Pfizer to Accelerate Discovery of Novel Precision Allosteric Therapeutics1 January 2025
Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of Circular RNANews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe